By driving forward education, research, and patient advocacy together, PAS is striving to make treatment for Pernicious Anaemia a safe, sustainable, and symptom-free reality for every person.
Sleep and stress: Cortisol breaks down collagen faster than GHK-Cu signals can rebuild it
Hemoglobin Production and Oxygen Transport Iron is a key part of hemoglobin
We recommend consulting with a qualified provider, such as our experienced providers at URBAN Medical, to determine the appropriate dosing schedule tailored to your individual needs
Results depend on consistency, lifestyle factors, and individual metabolism
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile